CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis
about
Arginine methyltransferases as novel therapeutic targets for breast cancerEpigenetic determinants of metastasisJMJD6 and U2AF65 co-regulate alternative splicing in both JMJD6 enzymatic activity dependent and independent manner.CARM1 and BAF155: an example of how chromatin remodeling factors can be relocalized and contribute to cancerGlobal mapping of CARM1 substrates defines enzyme specificity and substrate recognition.Tudor Domain Containing Protein 3 Promotes Tumorigenesis and Invasive Capacity of Breast Cancer CellsPRMT4-mediated arginine methylation negatively regulates retinoblastoma tumor suppressor protein and promotes E2F-1 dissociationIL-13Rα2 mediates PNR-induced migration and metastasis in ERα-negative breast cancer.Differential CARM1 Isoform Expression in Subcellular Compartments and among Malignant and Benign Breast Tumors.Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.Reciprocal Regulation of ERα and ERβ Stability and Activity by Diptoindonesin G.Centrosome amplification induces high grade features and is prognostic of worse outcomes in breast cancer.MicroRNA-16 suppresses metastasis in an orthotopic, but not autochthonous, mouse model of soft tissue sarcoma.MED12 methylation by CARM1 sensitizes human breast cancer cells to chemotherapy drugsNovel CARM1-Interacting Protein, DZIP3, Is a Transcriptional Coactivator of Estrogen Receptor-αIdentification of Selective Lead Compounds for Treatment of High-Ploidy Breast CancerRegulation of Transcription Factor Yin Yang 1 by SET7/9-mediated Lysine Methylation.A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.The BAF chromatin remodelling complex is an epigenetic regulator of lineage specification in the early mouse embryoTumor Cell-Driven Extracellular Matrix Remodeling Drives Haptotaxis during Metastatic Progression.Targeting synthetic lethality between the SRC kinase and the EPHB6 receptor may benefit cancer treatment.Linking long non-coding RNAs and SWI/SNF complexes to chromatin remodeling in cancer.miR-195 enhances the radiosensitivity of colorectal cancer cells by suppressing CARM1.Role of PRMTs in cancer: Could minor isoforms be leaving a mark?A rationale to target the SWI/SNF complex for cancer therapy.Vulnerabilities of mutant SWI/SNF complexes in cancer.Expanding the genetic editing tool kit: ZFNs, TALENs, and CRISPR-Cas9.The roles of ncRNAs and histone-modifiers in regulating breast cancer stem cells.Progress and challenges in predicting protein methylation sites.Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.The role of PRMT1 in EGFR methylation and signaling in MDA-MB-468 triple-negative breast cancer cells.MENA Confers Resistance to Paclitaxel in Triple-Negative Breast Cancer.Protein arginine methylation/demethylation and cancer.The story of protein arginine methylation: characterization, regulation, and function.The Overexpression of CARM1 Promotes Human Osteosarcoma Cell Proliferation through the pGSK3β/β-Catenin/cyclinD1 Signaling Pathway.O-GlcNAcylation of co-activator-associated arginine methyltransferase 1 regulates its protein substrate specificity.Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.Methylation of transcription factor YY2 regulates its transcriptional activity and cell proliferation.Casein kinase 2-mediated phosphorylation of Brahma-related gene 1 controls myoblast proliferation and contributes to SWI/SNF complex composition.
P2860
Q26851594-C80F4F5B-728B-466D-89C7-80C923948F8AQ28079377-A17D5106-2B3F-413A-A7C8-9A31475E617CQ33558243-6D001383-0DE9-4B3A-8EA8-183C9A3BF94CQ33739791-0A0C0A2F-4804-49C3-8917-475F0167E6A9Q33761232-2543BC9E-5FB3-4850-A071-18B39536AB36Q33894997-0A7FCA63-1650-4E98-B0CF-B0964A46564DQ34968529-68BA0B2F-D494-47C2-8563-04C6C6ACB883Q35064635-2A23014D-C0AC-4938-9D2C-AD450495C2F7Q35673016-68E22AF8-5DC6-45AD-AA3A-948B7B3FD7FEQ35769433-96D777AB-CA8F-44EC-9DD9-77E6B353E8E7Q35869243-1EBB3E33-74FE-464F-80F4-3F91325E9A3FQ35911257-D22ABF56-A3D5-436D-A463-C3B6732A894EQ35923419-68B668BD-4560-4CAD-847E-E97BD54F3E8CQ36284814-26B69778-0BDC-4F68-BDF3-0A11B9FEE6ABQ36331785-9C935A33-79F4-43D1-AE6F-E0DFC9815492Q36447691-CB9BAA12-A043-49F4-A0CB-D9793756B7AEQ36605841-A431C468-2648-4EF2-AF0A-F4654B79BC78Q36703511-E115FF6E-F596-4737-93D6-289545F28189Q36856095-8D60F10C-BAED-43E2-8782-19DFF6322A9CQ36863210-1B540C17-A167-4EBC-A08F-88CCFF974A26Q37580359-C985DA12-FA25-4C19-A0E1-9F9BF45589FFQ37650946-913ED4D3-2F64-4FFD-A986-584D44EBC336Q37664798-F6683EA7-FD35-4D5A-BC44-6956265203C7Q38219647-7F4D7F3E-A0E0-4BFC-B35D-B7CB8EEDCA79Q38220523-EE6C6CA6-BB28-461A-891D-A0A8F20CDFE8Q38247363-697E8C8C-7C6E-40DC-8C13-647BDAC7317CQ38255828-4EC6DD56-B60B-482F-A9F3-A4CAE255804FQ38263985-01A834BC-5CB4-4E4A-8B6B-DBA76DDF7E18Q38529273-70591EAD-8CB3-46D3-8DD9-E2E41298F51EQ38707876-96355BAB-AB3F-4F48-B424-EC2718ED4884Q38712750-A5426A3B-7093-4AD4-BCFB-6F8324ACA17EQ38733113-4B532EA3-FD06-415F-8BA0-3943778224BFQ38935888-7CA48289-EFDE-4649-8203-2A1CCE1B8110Q39064771-F11AFB43-22E7-4B76-B7A3-15DE66532438Q41036174-D1193DD7-5957-4A2D-A2D8-4C28210E6683Q41587950-35E881F3-F4E4-4DC1-AEF2-56A2F9B17A66Q42317508-9F30257D-B9B5-4095-8112-942BE8E346B2Q42383290-A0616A78-DED0-468D-9C41-BBA7D36AEA6CQ42778389-7875B8E2-FDC8-49CD-B125-D1BD2D488A74Q45169846-32368803-F8DC-4AAB-A2FE-A58BDE404CDF
P2860
CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
CARM1 methylates chromatin rem ...... mor progression and metastasis
@ast
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en-gb
CARM1 methylates chromatin rem ...... mor progression and metastasis
@nl
type
label
CARM1 methylates chromatin rem ...... mor progression and metastasis
@ast
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en-gb
CARM1 methylates chromatin rem ...... mor progression and metastasis
@nl
prefLabel
CARM1 methylates chromatin rem ...... mor progression and metastasis
@ast
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en-gb
CARM1 methylates chromatin rem ...... mor progression and metastasis
@nl
P2093
P2860
P3181
P1433
P1476
CARM1 methylates chromatin rem ...... mor progression and metastasis
@en
P2093
J Wesley Pike
Kari B Wisinski
Mark B Meyer
Menggang Yu
Paul Ahlquist
Sandeep Saha
P2860
P3181
P356
10.1016/J.CCR.2013.12.007
P407
P50
P577
2014-01-01T00:00:00Z